annual CFO:
-$492.60M-$4.03B(-113.93%)Summary
- As of today (May 21, 2025), VRTX annual cash flow from operations is -$492.60 million, with the most recent change of -$4.03 billion (-113.93%) on December 31, 2024.
- During the last 3 years, VRTX annual CFO has fallen by -$3.14 billion (-118.63%).
- VRTX annual CFO is now -111.93% below its all-time high of $4.13 billion, reached on December 31, 2022.
Performance
VRTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$818.90M+$234.30M(+40.08%)Summary
- As of today (May 21, 2025), VRTX quarterly cash flow from operations is $818.90 million, with the most recent change of +$234.30 million (+40.08%) on March 31, 2025.
- Over the past year, VRTX quarterly CFO has dropped by -$487.70 million (-37.33%).
- VRTX quarterly CFO is now -40.22% below its all-time high of $1.37 billion, reached on September 30, 2024.
Performance
VRTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$980.30M-$487.70M(-99.01%)Summary
- As of today (May 21, 2025), VRTX TTM cash flow from operations is -$980.30 million, with the most recent change of -$487.70 million (-99.01%) on March 31, 2025.
- Over the past year, VRTX TTM CFO has dropped by -$4.92 billion (-124.86%).
- VRTX TTM CFO is now -122.38% below its all-time high of $4.38 billion, reached on September 30, 2023.
Performance
VRTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -113.9% | -37.3% | -124.9% |
| 3 y3 years | -118.6% | -14.4% | -136.6% |
| 5 y5 years | -131.4% | +0.4% | -147.6% |
VRTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.9% | at low | -40.2% | +121.8% | -122.4% | at low |
| 5 y | 5-year | -111.9% | at low | -40.2% | +121.8% | -122.4% | at low |
| alltime | all time | -111.9% | +22.5% | -40.2% | +121.8% | -122.4% | at low |
VRTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $818.90M(+40.1%) | -$980.30M(+99.0%) |
| Dec 2024 | -$492.60M(-113.9%) | $584.60M(-57.3%) | -$492.60M(-41.5%) |
| Sep 2024 | - | $1.37B(-136.5%) | -$842.60M(-10.7%) |
| Jun 2024 | - | -$3.75B(-387.3%) | -$944.00M(-123.9%) |
| Mar 2024 | - | $1.31B(+456.9%) | $3.94B(+11.5%) |
| Dec 2023 | $3.54B(-14.3%) | $234.60M(-81.5%) | $3.54B(-19.3%) |
| Sep 2023 | - | $1.27B(+11.8%) | $4.38B(+7.7%) |
| Jun 2023 | - | $1.13B(+26.1%) | $4.07B(-0.1%) |
| Mar 2023 | - | $899.90M(-16.6%) | $4.07B(-1.4%) |
| Dec 2022 | $4.13B(+56.2%) | $1.08B(+12.9%) | $4.13B(+2.1%) |
| Sep 2022 | - | $955.50M(-16.2%) | $4.05B(+0.7%) |
| Jun 2022 | - | $1.14B(+19.2%) | $4.02B(+50.0%) |
| Mar 2022 | - | $956.20M(-3.9%) | $2.68B(+1.3%) |
| Dec 2021 | $2.64B(-18.7%) | $995.00M(+7.3%) | $2.64B(+23.5%) |
| Sep 2021 | - | $927.20M(-564.3%) | $2.14B(+0.9%) |
| Jun 2021 | - | -$199.70M(-121.7%) | $2.12B(-36.9%) |
| Mar 2021 | - | $921.00M(+87.4%) | $3.36B(+3.2%) |
| Dec 2020 | $3.25B(+107.3%) | $491.53M(-45.9%) | $3.25B(+1.4%) |
| Sep 2020 | - | $907.75M(-12.6%) | $3.21B(+21.7%) |
| Jun 2020 | - | $1.04B(+27.3%) | $2.63B(+27.9%) |
| Mar 2020 | - | $815.70M(+82.9%) | $2.06B(+31.3%) |
| Dec 2019 | $1.57B(+23.5%) | $445.98M(+33.2%) | $1.57B(+9.1%) |
| Sep 2019 | - | $334.79M(-27.8%) | $1.44B(-3.1%) |
| Jun 2019 | - | $463.75M(+42.8%) | $1.48B(+10.6%) |
| Mar 2019 | - | $324.78M(+3.2%) | $1.34B(+5.7%) |
| Dec 2018 | $1.27B(+50.3%) | $314.58M(-17.5%) | $1.27B(+7.4%) |
| Sep 2018 | - | $381.35M(+18.5%) | $1.18B(+21.7%) |
| Jun 2018 | - | $321.70M(+27.3%) | $971.96M(+16.8%) |
| Mar 2018 | - | $252.66M(+11.1%) | $831.91M(-1.5%) |
| Dec 2017 | $844.94M(+257.9%) | $227.51M(+33.8%) | $844.94M(+10.9%) |
| Sep 2017 | - | $170.09M(-6.4%) | $762.15M(+15.9%) |
| Jun 2017 | - | $181.65M(-31.6%) | $657.73M(+27.2%) |
| Mar 2017 | - | $265.69M(+83.6%) | $516.93M(+118.9%) |
| Dec 2016 | $236.10M(-164.6%) | $144.72M(+120.4%) | $236.10M(+95.9%) |
| Sep 2016 | - | $65.66M(+60.7%) | $120.52M(-1772.3%) |
| Jun 2016 | - | $40.86M(-369.9%) | -$7.21M(-95.4%) |
| Mar 2016 | - | -$15.14M(-151.9%) | -$158.33M(-56.7%) |
| Dec 2015 | -$365.43M(-36.2%) | $29.14M(-146.9%) | -$365.43M(-36.6%) |
| Sep 2015 | - | -$62.07M(-43.7%) | -$576.36M(-4.2%) |
| Jun 2015 | - | -$110.27M(-50.4%) | -$601.93M(-2.8%) |
| Mar 2015 | - | -$222.24M(+22.3%) | -$619.59M(+8.1%) |
| Dec 2014 | -$573.11M(+844.7%) | -$181.78M(+107.4%) | -$573.11M(+54.2%) |
| Sep 2014 | - | -$87.65M(-31.5%) | -$371.57M(+24.8%) |
| Jun 2014 | - | -$127.92M(-27.2%) | -$297.64M(+74.4%) |
| Mar 2014 | - | -$175.76M(-989.5%) | -$170.65M(+181.3%) |
| Dec 2013 | -$60.67M(-122.7%) | $19.76M(-244.0%) | -$60.67M(+52.2%) |
| Sep 2013 | - | -$13.72M(+1380.0%) | -$39.87M(-149.9%) |
| Jun 2013 | - | -$927.00K(-98.6%) | $79.81M(-59.9%) |
| Mar 2013 | - | -$65.78M(-262.2%) | $199.15M(-25.6%) |
| Dec 2012 | $267.84M(+86.3%) | $40.56M(-61.7%) | $267.84M(-63.4%) |
| Sep 2012 | - | $105.96M(-10.5%) | $730.95M(+9.4%) |
| Jun 2012 | - | $118.41M(+3960.5%) | $667.88M(+100.4%) |
| Mar 2012 | - | $2.92M(-99.4%) | $333.28M(+131.9%) |
| Dec 2011 | $143.74M(-122.6%) | $503.66M(+1074.2%) | $143.74M(-127.3%) |
| Sep 2011 | - | $42.90M(-119.8%) | -$526.03M(-28.2%) |
| Jun 2011 | - | -$216.19M(+15.8%) | -$732.92M(+17.2%) |
| Mar 2011 | - | -$186.63M(+12.4%) | -$625.61M(-1.5%) |
| Dec 2010 | -$635.44M(+48.6%) | -$166.10M(+1.3%) | -$635.44M(+11.2%) |
| Sep 2010 | - | -$163.99M(+50.6%) | -$571.67M(+33.2%) |
| Jun 2010 | - | -$108.89M(-44.6%) | -$429.31M(-2.1%) |
| Mar 2010 | - | -$196.46M(+92.0%) | -$438.49M(+2.5%) |
| Dec 2009 | -$427.59M(+88.8%) | -$102.33M(+373.0%) | -$427.59M(+1.2%) |
| Sep 2009 | - | -$21.64M(-81.7%) | -$422.48M(-20.0%) |
| Jun 2009 | - | -$118.06M(-36.4%) | -$528.33M(+72.4%) |
| Mar 2009 | - | -$185.56M(+90.9%) | -$306.51M(+35.3%) |
| Dec 2008 | -$226.48M | -$97.22M(-23.7%) | -$226.48M(+24.5%) |
| Sep 2008 | - | -$127.48M(-222.9%) | -$181.95M(+54.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $103.76M(-198.3%) | -$118.11M(-59.3%) |
| Mar 2008 | - | -$105.53M(+100.3%) | -$290.20M(+14.9%) |
| Dec 2007 | -$252.48M(+1023.4%) | -$52.69M(-17.2%) | -$252.48M(+23.7%) |
| Sep 2007 | - | -$63.64M(-6.9%) | -$204.07M(+424.2%) |
| Jun 2007 | - | -$68.33M(+0.8%) | -$38.93M(+31.6%) |
| Mar 2007 | - | -$67.81M(+1481.7%) | -$29.57M(+31.6%) |
| Dec 2006 | -$22.48M(-86.9%) | -$4.29M(-104.2%) | -$22.48M(-10.8%) |
| Sep 2006 | - | $101.50M(-272.1%) | -$25.19M(-86.2%) |
| Jun 2006 | - | -$58.98M(-2.8%) | -$183.00M(+2.9%) |
| Mar 2006 | - | -$60.71M(+766.9%) | -$177.93M(+3.4%) |
| Dec 2005 | -$172.05M(+21.0%) | -$7.00M(-87.6%) | -$172.05M(-8.8%) |
| Sep 2005 | - | -$56.31M(+4.5%) | -$188.69M(+7.2%) |
| Jun 2005 | - | -$53.91M(-1.7%) | -$176.06M(+21.3%) |
| Mar 2005 | - | -$54.83M(+131.9%) | -$145.12M(+2.1%) |
| Dec 2004 | -$142.16M(-15.2%) | -$23.64M(-45.9%) | -$142.16M(-3.4%) |
| Sep 2004 | - | -$43.67M(+90.1%) | -$147.22M(-3.2%) |
| Jun 2004 | - | -$22.97M(-55.7%) | -$152.08M(-10.2%) |
| Mar 2004 | - | -$51.87M(+80.7%) | -$169.42M(+1.1%) |
| Dec 2003 | -$167.62M(+110.7%) | -$28.70M(-40.9%) | -$167.62M(+10.0%) |
| Sep 2003 | - | -$48.53M(+20.4%) | -$152.40M(+24.8%) |
| Jun 2003 | - | -$40.32M(-19.5%) | -$122.15M(+23.0%) |
| Mar 2003 | - | -$50.07M(+271.6%) | -$99.33M(+24.9%) |
| Dec 2002 | -$79.54M(+1028.7%) | -$13.48M(-26.3%) | -$79.54M(+234.1%) |
| Sep 2002 | - | -$18.29M(+4.5%) | -$23.81M(-45.3%) |
| Jun 2002 | - | -$17.50M(-42.2%) | -$43.55M(+51.2%) |
| Mar 2002 | - | -$30.28M(-171.7%) | -$28.80M(+308.7%) |
| Dec 2001 | -$7.05M(-44.5%) | $42.26M(-211.1%) | -$7.05M(-88.1%) |
| Sep 2001 | - | -$38.03M(+1284.5%) | -$59.19M(+88.5%) |
| Jun 2001 | - | -$2.75M(-67.8%) | -$31.41M(+452.6%) |
| Mar 2001 | - | -$8.52M(-13.8%) | -$5.68M(-55.3%) |
| Dec 2000 | -$12.71M(-60.0%) | -$9.89M(-3.5%) | -$12.71M(-299.2%) |
| Sep 2000 | - | -$10.25M(-144.6%) | $6.38M(+108.3%) |
| Jun 2000 | - | $22.98M(-247.8%) | $3.06M(-109.4%) |
| Mar 2000 | - | -$15.55M(-269.0%) | -$32.45M(+2.0%) |
| Dec 1999 | -$31.80M(+2.3%) | $9.20M(-167.8%) | -$31.80M(-38.6%) |
| Sep 1999 | - | -$13.56M(+8.2%) | -$51.80M(+39.1%) |
| Jun 1999 | - | -$12.54M(-15.9%) | -$37.23M(+10.2%) |
| Mar 1999 | - | -$14.90M(+38.0%) | -$33.80M(+8.7%) |
| Dec 1998 | -$31.10M(+230.9%) | -$10.80M(-1180.0%) | -$31.10M(+30.7%) |
| Sep 1998 | - | $1.00M(-111.0%) | -$23.80M(-13.8%) |
| Jun 1998 | - | -$9.10M(-25.4%) | -$27.60M(+46.0%) |
| Mar 1998 | - | -$12.20M(+248.6%) | -$18.90M(+101.1%) |
| Dec 1997 | -$9.40M(-76.7%) | -$3.50M(+25.0%) | -$9.40M(+6.8%) |
| Sep 1997 | - | -$2.80M(+600.0%) | -$8.80M(-31.8%) |
| Jun 1997 | - | -$400.00K(-85.2%) | -$12.90M(-62.8%) |
| Mar 1997 | - | -$2.70M(-6.9%) | -$34.70M(-13.9%) |
| Dec 1996 | -$40.30M(+151.9%) | -$2.90M(-58.0%) | -$40.30M(+8.6%) |
| Sep 1996 | - | -$6.90M(-68.9%) | -$37.10M(+7.2%) |
| Jun 1996 | - | -$22.20M(+167.5%) | -$34.60M(+79.3%) |
| Mar 1996 | - | -$8.30M(-2866.7%) | -$19.30M(+20.6%) |
| Dec 1995 | -$16.00M(+8.8%) | $300.00K(-106.8%) | -$16.00M(-26.3%) |
| Sep 1995 | - | -$4.40M(-36.2%) | -$21.70M(+9.0%) |
| Jun 1995 | - | -$6.90M(+38.0%) | -$19.90M(+22.8%) |
| Mar 1995 | - | -$5.00M(-7.4%) | -$16.20M(+10.2%) |
| Dec 1994 | -$14.70M(-270.9%) | -$5.40M(+107.7%) | -$14.70M(-1570.0%) |
| Sep 1994 | - | -$2.60M(-18.8%) | $1.00M(-73.0%) |
| Jun 1994 | - | -$3.20M(-8.6%) | $3.70M(-47.1%) |
| Mar 1994 | - | -$3.50M(-134.0%) | $7.00M(-18.6%) |
| Dec 1993 | $8.60M(-262.3%) | $10.30M(>+9900.0%) | $8.60M(-368.8%) |
| Sep 1993 | - | $100.00K(0.0%) | -$3.20M(-31.9%) |
| Jun 1993 | - | $100.00K(-105.3%) | -$4.70M(-19.0%) |
| Mar 1993 | - | -$1.90M(+26.7%) | -$5.80M(+9.4%) |
| Dec 1992 | -$5.30M(+112.0%) | -$1.50M(+7.1%) | -$5.30M(+39.5%) |
| Sep 1992 | - | -$1.40M(+40.0%) | -$3.80M(+58.3%) |
| Jun 1992 | - | -$1.00M(-28.6%) | -$2.40M(+71.4%) |
| Mar 1992 | - | -$1.40M | -$1.40M |
| Dec 1991 | -$2.50M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual CFO year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly CFO year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM CFO year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cash flow from operations?
The current annual CFO of VRTX is -$492.60M
What is the all time high annual CFO for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cash flow from operations is $4.13B
What is Vertex Pharmaceuticals Incorporated annual CFO year-on-year change?
Over the past year, VRTX annual cash flow from operations has changed by -$4.03B (-113.93%)
What is Vertex Pharmaceuticals Incorporated quarterly cash flow from operations?
The current quarterly CFO of VRTX is $818.90M
What is the all time high quarterly CFO for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cash flow from operations is $1.37B
What is Vertex Pharmaceuticals Incorporated quarterly CFO year-on-year change?
Over the past year, VRTX quarterly cash flow from operations has changed by -$487.70M (-37.33%)
What is Vertex Pharmaceuticals Incorporated TTM cash flow from operations?
The current TTM CFO of VRTX is -$980.30M
What is the all time high TTM CFO for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cash flow from operations is $4.38B
What is Vertex Pharmaceuticals Incorporated TTM CFO year-on-year change?
Over the past year, VRTX TTM cash flow from operations has changed by -$4.92B (-124.86%)